LINAFEXOR

LIVE

Serial Number

79427316

Owner

Cascade Pharmaceuticals, Inc

Attorney

Priscilla Lauren Speer

Filing Date

May 27, 2025

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

LINAFEXOR Trademark

Serial Number: 79427316 • Registration: 8268547

LINAFEXOR is a trademark filed by Cascade Pharmaceuticals, Inc on May 27, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Cascade Pharmaceuticals, Inc (6 trademarks)

Building 10,

Entity Type: 03

Legal Representation

Attorney of Record

Priscilla Lauren Speer

1,086 trademarks filed View all →

Correspondence Address

Priscilla Lauren Speer Bayramoglu Law Offices LLC

1540 West Warm Springs Road

Henderson, NV 89014

United States

Trademark Details

Filing Date

May 27, 2025

Registration Date

May 26, 2026

Published for Opposition

April 7, 2026

Goods & Services

Pharmaceutical drugs for medical purposes for the treatment of Metabolic diseases and Inflammation; organotherapy preparations; biological preparations for medical purposes for the treatment of Metabolic diseases and Inflammation; medicines for human purposes for the treatment of Metabolic diseases and Inflammation; chemical preparations for medical purposes for the treatment of Metabolic diseases and Inflammation; surgical implants comprised of living tissues; stem cells for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB

Jun 25, 2026 ADCH

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 26, 2026 NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 26, 2026 NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 26, 2026 NRCC

REGISTERED-PRINCIPAL REGISTER

May 26, 2026 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 7, 2026 NPUB

PUBLISHED FOR OPPOSITION

Apr 7, 2026 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 1, 2026 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 15, 2026 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 13, 2026 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 13, 2026 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 13, 2026 TROA

REFUSAL PROCESSED BY IB

Oct 31, 2025 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Oct 13, 2025 RFCS

REFUSAL PROCESSED BY MPU

Oct 13, 2025 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Aug 28, 2025 RFCR

NON-FINAL ACTION WRITTEN

Aug 27, 2025 CNRT

ASSIGNED TO EXAMINER

Aug 21, 2025 DOCK

APPLICATION FILING RECEIPT MAILED

Jul 11, 2025 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 11, 2025 NWOS

SN ASSIGNED FOR SECT 66A APPL FROM IB

Jul 10, 2025 REPR

Related Trademarks

More from this Owner

Serial #79427213

Serial #79416292

More in Same Class

MONDAY.

BIOEMBRACE

DIETARY SUPPLEMENTS, OVER THE COUNTER PRODUCTS, NUTRACEUTICALS AND PHYTO-PHARMACEUTICALS FOR USE IN BONE AND JOINT CONDITIONS. PHARMACEUTICAL AND NUTRACEUTICAL MIXTURES CONSISTING OF A SYNERGISTIC AND SPECIALIZED BLEND OF CERTAIN NATURAL PLANT-BASED INGREDIENTS IN TABLET, CAPSULE, ORAL LIQUIDS, TOPICAL PREPARATIONS AND ANY OTHER DOSAGE FORMS TO BE USED FOR BONE AND JOINT, AND DEGENERATIVE CONDITIONS.

ZEAL& ZEALAND PHARMA

VIVEDERMA

WIZSO